RxDoctor Payments Data

Patrick Griffith, MD

Interventional Pain Medicine · North Kansas City, MONPI 1366524076

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.7% of the total across 247 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Medtronic at 44.2% of the total. Reporting peaked in 2023 at $1,067 and has fallen 97.9% since, to $23 in 2025.

$3,239in general payments, 2019–2025

Across 247 payments — averaging $13.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Boston Scientific$571
  • Nevro Corp.$540
  • Relievant Medsystems, Inc.$293
  • SPR Therapeutics, Inc$212
  • Abiomed$168
  • plus $24 from 2 others

What the payments were for

  • Travel & lodging$2648%
  • Food & beverage$2,97092%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,239 in reported general payments places this provider in the 55th percentile of 27 interventional pain medicine providers in Missouri.

See all interventional pain medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$240,487
Medicare patients
470
Services billed
2,052

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen506$11,079
Pregabalin238$5,815
Gabapentin279$5,409
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen169$5,082
Oxycodone Hcl176$3,932
Morphine Sulfate ErMorphine Sulfate71$1,572
Tramadol Hcl159$1,379
Baclofen45$920
Duloxetine Hcl39$862
Methadone Hcl29$589
Celecoxib14$560
Tizanidine Hcl40$361
Hydromorphone Hcl14$275
Ibuprofen11$222
Lorazepam92$194

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in North Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →